Literature DB >> 24905323

Combination therapy of gamma-aminobutyric acid derivative promotes proton pump inhibitor based healing of reflux esophagitis in animal model.

Pradeep Khinchi1, Sudipta Saha1, Shubhini A Saraf1, Gaurav Kaithwas2.   

Abstract

BACKGROUND: The present study was undertaken to elucidate the effect of omeprazole and baclofen on experimental esophagitis in albino rats.
METHODS: Groups of rats, fasted overnight received normal saline (3 ml/kg, ip; sham control) or toxic control (3 ml/kg, ip) or omeprazole (30 mg/kg, ip) or baclofen (20 mg/kg, ip) or their combinations, were subjected to the pylorus and forestomach ligation. Animals were sacrificed after 6 h and evaluated for the gastric pH, volume of gastric juices, total acidity, esophagitis index and free acidity. Esophageal tissues were further subjected to estimations of TBARS, GSH, catalase and SOD.
RESULTS: Treatment with omeprazole and baclofen significantly inhibited the gastric secretion, total acidity and esophagitis index. The treatment also helped to restore the altered level's oxidative stress parameters to normal.
CONCLUSION: The beneficial effect of omeprazole and baclofen against GERD could be conglomerately attributed to the antisectretory action of omeprazole and reduction in the tracheal lower esophageal sphincter release rate by baclofen.
Copyright © 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Antisecretory; Baclofen; Esophagitis; Gamma-aminobutyric acid; Omeprazole

Mesh:

Substances:

Year:  2014        PMID: 24905323     DOI: 10.1016/j.pharep.2013.06.011

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  5 in total

1.  Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis.

Authors:  C-H Chen; C-L Lin; C-H Kao
Journal:  Osteoporos Int       Date:  2016-02-10       Impact factor: 4.507

2.  Pectin-encrusted gold nanocomposites containing phytic acid and jacalin: 1,2-dimethylhydrazine-induced colon carcinogenesis in Wistar rats, PI3K/Akt, COX-2, and serum metabolomics as potential targets.

Authors:  Malti Arya; Pooja Singh; Chandra B Tripathi; Poonam Parashar; Mahendra Singh; Jovita Kanoujia; Anupam Guleria; Gaurav Kaithwas; Krishna P Gupta; Shubhini A Saraf
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

3.  Effect of lycopene against gastroesophageal reflux disease in experimental animals.

Authors:  Arvind Kumar Giri; Jitendra Kumar Rawat; Manjari Singh; Swetlana Gautam; Gaurav Kaithwas
Journal:  BMC Complement Altern Med       Date:  2015-04-09       Impact factor: 3.659

4.  Effect of monotherapy and combination therapy of pantoprazole and aprepitant in gastric esophageal reflux disease in albino rats.

Authors:  Kamleshwar Shukla; Prince Raj; Arun Kumar; Mukesh Kumar; Gaurav Kaithwas
Journal:  ScientificWorldJournal       Date:  2014-03-23

5.  Rutin attenuates intestinal toxicity induced by Methotrexate linked with anti-oxidative and anti-inflammatory effects.

Authors:  Raju Gautam; Manjari Singh; Swetlana Gautam; Jitendra Kumar Rawat; Shubhini A Saraf; Gaurav Kaithwas
Journal:  BMC Complement Altern Med       Date:  2016-03-10       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.